Meningitec Teresa Davis 2011 Meningitec Ø Meningococcal

Meningitec Teresa Davis 2011

Meningitec Ø Meningococcal Serogroup C Conjugate Vaccine Ø 1 of 3 vaccines to protect against Neisseria meningitidis group C Ø Does not proctect against A B W Y

Active Ingredients Ø Each. 5 ml dose contains 10 ug of Neisseria meningitidis Serogroup C oligosaccharide conjugated to 15 ug Diphtheriae carrier protein. Ø Aluminium phosphate Ø Sodium chloride Ø H 2 O

Presentation Ø Prefilled syringe – without a needle Ø. 5 ml Ø White suspension

Indications Ø For active immunisation from 6 weeks of age to prevent Neisseria meningitidis serogroup C Ø Not recommended in any elderly populations

Contradications Ø Hypersensitivity of any components of the vaccine Ø Any significant neurological s&s or allergic or anaphylactic reaction to prior dose of Meningitec Ø Severe febrile illness Ø Does not contain eggs or nuts

Precautions Ø Coagulation disorders – only because of the IM injection Ø Impaired immune responsive patients – may have a reduce antibody response to active immunisation Ø Not recommended for pregnant or lactating mothers

Interactions Ø Can be administered at the same time as -Oral Polio, Hep B, Hib, DTa. P and DT whole cell Pertussis, PCV 7 and MMR Ø Lower levels of Meningococcal C antibodies have been reported with co-administration of Meningitec and a. P Ø Spacing either simultaneously or at any time before or after

Storage Ø Keep in original packaging Ø Refrigerate between 2 and 8 degrees Celsius Ø If exposed to temps above 8 degrees Celsius for 48 hrs accumulatively – must be destroyed. Ø DO NOT freeze

Administration Ø Shake well before use Ø IM injection only Ø Anterolateral thigh in infants and deltoid in older children, adolescents and adults Ø NOT the gluteal area

Common (Mild) Adverse Reactions Ø Ø Ø Local reaction Headache, dizziness and light-headedness Aching muscles Sleepiness or unsettled sleep Feeling unwell Unusual high- pitched cry Reduced eating and drinking D’s and V’s Stomach cramps or pain Dyspepsia Fever

Very Rare Adverse Events Ø Swollen glands in neck, armpits or groin Ø HHE – hyptonic, hyporesponsive episode Ø Pins and needles Ø Petechiae or purpura Ø Loss of muscle tone Ø Decreased sensitivity to touch.

Ordering

Whangarei FAX TO: 09 -438 -9681 Northland District Health Board (NDHB) Meningitec Vaccine Fax Order Form Account Name: Account No: Delivery Address: Date Required: Contact Name: Contact Phone: Special Delivery Instructions: Proprietary name (manufacturer) of currently supplied vaccine Vaccine Description Meningococcal Serogroup C Conjugate Vaccine . 5 ml No of doses per pfs Meningitec (Pfizer) 1 Minimum quantity to order ? PRP CODE No of doses required 1112045 Please note: If ordering in large volumes, it is recommended that you order the Meningitec vaccine in multiples of 7 0 doses as this will be the optimum quantity per chilly bin.

Ø Authorised Vaccinator Ø Standing Orders Ø Perscription

APPLICATION FOR AUTHORISATION OF CURRENTLY AUTHORISED VACCINATORS FOR THE MENINGOCOCCAL C VACCINATION PROGRAMME VACCINATOR’S NAME: ………………………. . ……… WORK POSTAL ADDRESS: ………………………………. WORK PHONE NUMBER: ………………………………… Meningococcal C Immunisation Programme approved by the Medical Officer of Health , Northland District Health Board. Please provide the following: A copy of your current non-medical vaccinator authorisation Please note that vaccinators intending to vaccinate in community-based settings (outreach or offsite) will also need to attach a copy of their Northland DHB Clinical Audit for Community-based Vaccinators. 1. A copy of your current practicing certificate. Evidence of indemnity insurance □ I have read the Meningitec® data sheet OR attended a Meningococcal C programme CNE session. Name: …………………………………… Signed: …………………………………… Date: ……/……/11

Out of the Programme Dosage Ø For infants less than 12 months - three doses at least 1 month apart - with a booster dose at or after 12 months Ø Very pre term babies – risk of apnoea – give and monitor

References Ø Consumer and Health Professional data sheets Ø Immunisation Handbook 2011 Ø Med Division Pfizer Australia

Measles Ø Monday 3 Oct Ø 200 confirmed cases of measles in the Auckland region since 30 May Ø 0900 hour 10 confirmed cases reported between Friday 9 am and Monday 9 am Ø a further 8 suspected cases under investigation